<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01580436</url>
  </required_header>
  <id_info>
    <org_study_id>TVP Study</org_study_id>
    <nct_id>NCT01580436</nct_id>
  </id_info>
  <brief_title>Prophylactic Tricuspid Valve Annuloplasty in Patients Undergoing Mitral Valve Surgery</brief_title>
  <official_title>Prospective, Randomized Evaluation of Prophylactic Tricuspid Valve Annuloplasty in Patients Undergoing Mitral Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      De novo or progressive tricuspid regurgitation (TR) is not uncommonly observed following
      mitral valve surgery and associated with worse outcome. Hence, concomitant tricuspid valve
      annuloplasty (TVP) has been recommended for patients undergoing mitral valve surgery when
      tricuspid annular dilatation is present even in absence of significant TR. However, whether
      such a strategy of &quot;prophylactic TVP&quot; results in improved outcomes has not been shown to date
      by a prospective randomized study. The investigators goal is therefore to initiate such a
      study and evaluate the effect of concomitant TVP on mid- and long-term outcome in patients
      scheduled for mitral valve surgery and tricuspid annular dilatation but &lt;2+ TR.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>combination of all-cause mortality or heart failure hospitalisation</measure>
    <time_frame>at 12 months post-surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>RV function &amp; geometry</measure>
    <time_frame>3, 6, 12 and 18 months</time_frame>
    <description>volumes and ejection fraction Assessed by cardiac ultrasound and MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6, 12 and 18 months</time_frame>
    <description>Change at follow-up, measured by SF-36 &amp; Minnesota Living with Heart Failure scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Hospital and ICU stay</measure>
    <time_frame>postoperative phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-Cause Mortality</measure>
    <time_frame>at 3, 6, 12 and 18 months post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization for Heart Failure</measure>
    <time_frame>at 3, 6, 12 and 18 months post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progressive TR &gt; 2+ post-surgery</measure>
    <time_frame>3, 6, 12 and 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiovascular mortality</measure>
    <time_frame>at 3, 6, 12 and 18 months post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Tolerance</measure>
    <time_frame>6, 12 and 18 months</time_frame>
    <description>Change at follow-up, by 6-minute walking distance and maximal exercise cyclo-ergometry (maximal aerobic capacity)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Tricuspid Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>Tricuspid Valve Annuloplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients, undergoing mitral valve surgery with no significant tricuspid valve regurgitation despite tricuspid annular dilation, randomized to concomitant tricuspid valve annuloplasty.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients, undergoing mitral valve surgery with no significant tricuspid valve regurgitation despite tricuspid annular dilation, randomized to mitral valve surgery without concomitant tricuspid valve annuloplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tricuspid Valve Annuloplasty</intervention_name>
    <description>Concomitant Tricuspid Valve Annuloplasty in patients undergoing mitral valve surgery</description>
    <arm_group_label>Tricuspid Valve Annuloplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for mitral valve surgery

          -  Tricuspid Annular diameter &gt; 40mm or &gt;21mm/mÂ²

        Exclusion Criteria:

          -  Tricuspid Regurgitation more than 2+

          -  Unable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David Verhaert, MD</last_name>
    <phone>+32 089 32 70 91</phone>
    <email>david.verhaert@zol.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chris Beerts</last_name>
    <phone>+32 089 32 71 91</phone>
    <email>chris.beerts@zol.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg (General Hospital Genk)</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Verhaert, MD</last_name>
      <phone>+32 089 32 70 91</phone>
      <email>david.verhaert@zol.be</email>
    </contact>
    <contact_backup>
      <last_name>Chris Beerts</last_name>
      <phone>+32 089 32 71 91</phone>
      <email>chris.beerts@zol.be</email>
    </contact_backup>
    <investigator>
      <last_name>Wilfried Mullens, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Dion, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pieter Vandervoort, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2011</study_first_submitted>
  <study_first_submitted_qc>April 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2012</study_first_posted>
  <last_update_submitted>October 23, 2014</last_update_submitted>
  <last_update_submitted_qc>October 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Wilfried Mullens, MD PhD</investigator_full_name>
    <investigator_title>Professor Cardiovascular Physiology</investigator_title>
  </responsible_party>
  <keyword>Tricuspid Valve Insufficiency</keyword>
  <keyword>Cardiac Valve Annuloplasty</keyword>
  <keyword>Outcome Assessment (Health Care)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

